Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report

Journal of Clinical Psychiatry

Volumn 69, Issue 8, 2008, Pages 1246-1256

  Gilmer, William S ^a   Gollan, Jackie K ^a   Wisniewski, Stephen R ^b   Howland, Robert H ^c   Trivedi, Madhukar H ^d   Miyahara, Sachiko ^b   Fleck, Jenelle ^a   Thase, Michael E ^e   Alpert, Jonathan E ^f   Nierenberg, Andrew A ^f   Warden, Diane ^d   Fava, Maurizio ^f   Rush, A John ^d  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CITALOPRAM; HYPNOTIC AGENT; NIRAVAM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE DURATION; DRUG DOSE INCREASE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR DEPRESSION; MALE; POST HOC ANALYSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SOCIOECONOMICS; SUICIDE; TREATMENT OUTCOME;

EID: 49649120470     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0807     Document Type: Article

References (53)

1. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917
2. Coryell W, Scheftner W, Keller M, et al. The enduring psychosocial consequences of mania and depression. Am J Psychiatry 1993;150:720-727
3. Judd LL, Akiskal HS, Paulus MP. The role and clinical significance of subsyndromal depressive symptoms (SSD) in unipolar major depressive disorder. J Affect Disord 1997;45:5-17
4. Hirschfeld RM, Dunner DL, Keitner G, et al. Does psychosocial functioning improve independent of depressive symptoms? a comparison of nefazodone, psychotherapy, and their combination. Biol Psychiatry 2002;51:123-133
5. Gilmer WS, Trivedi MH, Rush AJ, et al. Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand 2005;112:425-433
6. Keller MB, Lavori PW, Mueller TI, et al. Time to recovery, chronicity, and levels of psychopathology in major depression: a 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry 1992;49:809-816
7. Coryell W, Endicott J, Keller M. Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry 1990;147:1627-1633
8. Stewart JW, McGrath PJ, Quitkin FM, et al. Relevance of DSM-III depressive subtypes and chronicity of antidepressant efficacy in atypical depression: differential response to phenelzine, imipramine, and placebo. Arch Gen Psychiatry 1989;46:1080-1087
9. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006;163:28-40
10. Keller MB, Gelenberg AJ, Hirschfeld RM, et al. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry 1998;59:598-607
11. Kocsis JH, Frances AJ, Voss CB, et al. Imipramine treatment for chronic depression. Arch Gen Psychiatry 1988;45:253-257
12. Keller MB, McCullough JP, Klein DN, et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000;342:1462-1470
13. Stewart JE, McGrath PJ, Quitkin FM, et al. Chronic depression: response to placebo, imipramine, and phenelzine. J Clin Psychopharmacol 1993;13:391-396
14. Thase ME, Rush AJ, Howland RH, et al. Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression. Arch Gen Psychiatry 2002;59:233-239
15. Miller IW, Keitner GI, Schatzberg AF, et al. The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. J Clin Psychiatry 1998;59:608-619
16. Scott J, Eccleston D, Boys R. Can we predict the persistence of depression? Br J Psychiatry 1992;161:633-637
17. Brugha TS, Bebbington PE, MacCarthy B, et al. Gender, social support and recovery from depressive disorders: a prospective clinical study. Psychol Med 1990;20(1):147-156
18. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 2003;26:457-494
19. Rush AJ, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials 2004;25:119-142
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr 1960;23:56-61
21. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003;54:573-583
22. Trivedi MH, Rush AJ, Ibrahim HM, et al. The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation. Psychol Med 2004;34:73-82
23. Linn BS, Linn MW, Gurel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 1968;16:622-626
24. Rush AJ, Carmody T, Reimitz PE. The Inventory of Depressive Symptomatology (IDS): Clinician (IDS-C) and Self-Report (IDS-SR) ratings of depressive symptoms. Int J Meth Psychiatr Res 2000;9:45-59
25. Zimmerman M, Mattia JI. The reliability and validity of a screening questionnaire for 13 DSM-IV Axis I disorders (the Psychiatric Diagnostic Screening Questionnaire) in psychiatric outpatients. J Clin Psychiatry 1999;60:677-683
26. Rush AJ, Giles DE, Schlesser MA, et al. The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986;18:65-87
27. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996;26:477-486
28. Kobak KA, Greist JH, Jefferson JW, et al. Computerized assessment of depression and anxiety over the telephone using interactive voice response. MD Comput 1999;16:64-68
29. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull 1993;29:321-326
30. Ware JE, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233
31. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993;4:353-355
32. Mundt JC, Marks IM, Shear MK, et al. The Work and Social Adjustment Scale: a simple measure of impairment in functioning. Br J Psychiatry 2002;180:461-464
33. Wisniewski SR, Rush AJ, Balasubramani GK, et al. Self-rated global measure of the frequency, intensity, and burden of side effects. J Psychiatr Pract 2006;12:71-79
34. Nierenberg AA, Trivedi MH, Ritz L, et al. Suicide risk management for the sequenced treatment alternatives to relieve depression study: applied NIMH guidelines. J Psychiatr Res 2004;38:583-589
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders-Text Revision (DSM-IV-TR), 4th edition. Washington, DC: American Psychiatric Association; 2000
36. Maj M, Veltro F, Pirozzi R, et al. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992;149:795-800
37. Spijker J, de Graaf R, Bijl RV, et al. Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS). Br J Psychiatry 2002;181:208-213
38. Solomon DA, Keller MB, Leon AC, et al. Recovery from major depression: a 10-year prospective follow-up across multiple episodes. Arch Gen Psychiatry 1997;54:1001-1006
39. Angst J. The course of affective disorders. Psychopathology 1986;19:47-52
40. Savino M, Perugi G, Musetti L, et al. La depressione maggiore cronica: caratteristiche diagnostiche e cliniche. In: Reda GC, ed. Progressi in psiciatria. Rome, Italy: P. Pancheri; 1989
41. U.S. Census Bureau: Census 2000 PHC-T-1. Population by Race and Hispanic or Latino Origin for the United States: 1990 and 2000. Washington, DC: U.S. Census Bureau. Available at: http://www.census.gov/population/cen2000/phc-t1/ tab01.pdf. Accessed April 17, 2008
42. Keller MB, Harrison W, Fawcett JA, et al. Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community. Psychopharmacol Bull 1995;31:205-212
43. Akiskal HS, King D, Rosenthal TL, et al. Chronic depressions, pt 1: clinical and familial characteristics in 137 probands. J Affect Disord 1981;3:297-315
44. Berti-Ceroni GB, Neri C, Pezzoli A. Chronicity in major depression: a naturalistic prospective study. J Affect Disord 1984;7:123-132
45. Gaynes BN, Rush AJ, Trivedi M, et al. A direct comparison of presenting characteristics of depressed outpatients from primary vs. specialty care settings: preliminary findings from the STAR*D clinical trial. Gen Hosp Psychiatry 2005 Mar-Apr;27(2):87-96
46. Schatzberg AF, Rush JA, Bruce A, et al. Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not. Arch Gen Psychiatry 2005;62:513-520
47. Nemeroff CB, Heim CM, Thase ME, et al. Differential responses to psychotherapy versus pharmacotherapy in patients with chronic forms of major depression and childhood trauma. Proc Nat Acad Sci USA 2003;100:14293-14296
48. Hirschfeld RM, Klerman GL, Andreasen NC, et al. Psycho-social predictors of chronicity in depressed patients. Br J Psychiatry 1986;148:648-654
49. Scott J. Chronic depression. Br J Psychiatry 1988;153:287-297
50. Koscis JH, Mason BJ, Frances AJ, et al. Prediction of response of chronic depression to imipramine. J Affect Disord 1989;17:255-260
51. Russell JM, Kornstein SG, Shea MT, et al. Chronic depression and comorbid personality disorders: response to sertraline versus imipramine. J Clin Psychiatry 2003;64:554-561
52. Keller MB, Shapiro RW. "Double depression": superimposition of acute depressive episodes on chronic depressive disorders. Am J Psychiatry 1982;139:438-442
53. McCullough JP Jr, Klein DN, Borian FE, et al. Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, pt 2. J Abnorm Psychol 2003;112:614-622